Become a Patron!

This Early-Stage Biotech Stock Is Up 400% — Should You Buy Now?

Status
Not open for further replies.

VUBot

Staff member
Diamond Contributor
ECF Refugee
Vape Media
RNAAvidity Biosciences $44.98 -0.51 (-1.12%) (As of 08/16/2024 08:51 PM ET) - 52-Week Range - $4.82 ▼ $48.80 - Price Target - $54.83 Avidity Biosciences NASDAQ: RNA is a biopharmaceutical stock focusing on RNA therapeutics. The company’s stock is up around 400% so far in 2024. However, even with…

Continue reading...
 
Status
Not open for further replies.

VU Sponsors

Top